Dr. Herbert Lachman, a scientist at the Albert Einstein College of Medicine, and a JdVS Medical Advisory Board Member is one of the first researchers to use iPS cells to study neurodevelopmental disorders. He is also one of the first to use a gene editing tool called CRISPR to introduce IDD and autism mutations into…
Read MoreJansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome
Read MoreFeatured in the American Journal of Human Genetics.
Read More